ARIKAYCE® Prescription and Arikares® Support Program Enrollment Form
Resources for HCPs | ARIKAYCE® (amikacin liposome inhalation suspension)
Track Record - PARI
Insmed Incorporated: ARIKAYCE® | Emergo by UL
ARIKAYCE Instructions For Use
Arikayce: Package Insert - Drugs.com
Taking ARIKAYCE® | ARIKAYCE® (amikacin liposome inhalation suspension)
PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)
Pari Pharma lands FDA nod for Lamira nebulizer - Drug Delivery Business
Inhalation mit dem Lamira® Inhalationssystem - YouTube
eFlow®rapid | Components / preparation and inhalation - YouTube
ARIKAYCE® Prescription and Arikares® Support Program Enrollment Form
Lamira - PARI
207356Orig1s000
Taking ARIKAYCE® | ARIKAYCE® (amikacin liposome inhalation suspension)
LAMIRA®, an eFlow® Technology nebulizer, expected to launch in Japan as a medical device for exclusive administration of ARIKAYCE® (amikacin liposome inhalation suspension)
eFlow Technology Platform - PARI
207356Orig1s000
eFlow Technology Platform - PARI
